Next-Generation Surgical Mesh System for Personalized Soft Tissue Repair
Legal Citation
Summary of the Inventive Concept
A revolutionary surgical mesh system that integrates advanced materials, sensors, and bioactive agents to facilitate personalized soft tissue repair, enabling minimally invasive procedures, improved healing outcomes, and reduced defect recurrence.
Background and Problem Solved
The original segmented skirted surgical mesh patent, while effective, has limitations in terms of adaptability, biocompatibility, and healing promotion. The new inventive concept addresses these limitations by introducing a modular, sensor-enabled, and biohybrid approach that can be customized to specific defect geometries and patient needs.
Detailed Description of the Inventive Concept
The next-generation surgical mesh system comprises a base layer of surgical mesh with a self-healing material, and a segmented skirt of surgical mesh with adjustable segments that can be customized to fit specific defect geometries. The system can be infused with bioactive agents that promote tissue regeneration and may include integrated sensors for monitoring tissue healing. The modular design allows for interchangeable segmented skirts with varying geometries and materials to accommodate different defect types. Additionally, a computer-aided design system utilizing machine learning algorithms can generate customized mesh designs based on patient-specific defect geometries and tissue characteristics.
Novelty and Inventive Step
The new claims introduce a paradigm shift in surgical mesh technology by integrating advanced materials, sensors, and bioactive agents to facilitate personalized soft tissue repair. The inventive step lies in the combination of these features, which enables minimally invasive procedures, improved healing outcomes, and reduced defect recurrence.
Alternative Embodiments and Variations
Alternative embodiments may include the use of different self-healing materials, varying segmented skirt geometries, and alternative bioactive agents. Additionally, the system could be adapted for use in other medical applications, such as wound healing or tissue engineering.
Potential Commercial Applications and Market
The next-generation surgical mesh system has significant commercial potential in the medical device industry, particularly in the areas of soft tissue repair, wound healing, and tissue engineering. The target market includes hospitals, surgical centers, and medical research institutions, with potential for expansion into new markets and applications.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61F2/0063 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device engineering, specifically surgical mesh design for soft tissue reconstruction, requiring expertise in biomaterials, surgical techniques, and advanced medical device integration
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with advanced degrees, experience in surgical implant design, knowledge of material science, and familiarity with tissue repair technologies
Obviousness Rationale
A PHOSITA would recognize that the PTD's advanced surgical mesh system represents predictable variations on the source patent's fundamental segmented mesh design. The core structural elements of the segmented skirted surgical mesh remain consistent, with the PTD introducing incremental technological enhancements that would be obvious extensions of existing surgical mesh technologies. The modifications represent standard design optimization strategies commonly employed in medical device engineering.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,403 |
|---|---|
| Title | Segmented skirted surgical mesh |